The 20th anniversary edition of the CPHI Pharma Awards is now open for entries, with three new categories created to reflect the surge of innovation within the industry.
In the last year, pharma has continued its rapid rate of innovation embracing the speed of pandemic R&D, but added to this are new social goals that aim to improve the wider world as well as bottom lines and therapeutic/device options.
In total, the CPHI Pharma Awards will celebrate global leaders from across 12 categories, including returning categories spanning development and manufacturing of devices and drugs, alongside packaging, supply chain, sustainability, regulatory compliance, and the much-vaunted CEO of the Year award.
A new Start-up award has been specifically introduced to honour exhibitors from the start-up zone – a new part of CPHI Barcelona that celebrates the raft of recent start-ups. In this new era of global collaborative research, many of the biggest innovations emerge from some of the smallest companies and this category will span projects at proof-of-concept stage to prototype or commercial launch.
In a change from 2022 and to reflect the wider efforts of many companies, the Covid Response category is renamed the Accelerating Innovation award. The winner will be selected based on innovations used to help combat the impact of global healthcare emergencies or future health emergencies.
Finally, the new Heart of Pharma award will celebrate the acceleration of social, ethical and philanthropic activities. This is to recognise the individuals, companies or initiatives that have made the most significant contributions to improving patient engagement or centricity, promoted corporate social responsibility and/or improvements to healthcare accessibility and equity.
“One of the things we enjoy most at CPHI is celebrating the outstanding achievements of the industry in not just improving methods, processes and supply-side efficiencies but the real-world impacts these have on delivery and in improving patient outcomes and experiences. Pharma has always been an industry centred on innovation and this has accelerated post pandemic, and we see new developments coming from all sizes of companies and parts of the world. These are the leaders we will celebrate at the awards, and we look forward to reviewing entries submitted by the industry’s best and brightest. Our eponymous awards are your chance to be recognised among your peers at pharma’s largest global event,” added Tara Dougal, content director, Pharma at Informa.